These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 20490797)

  • 41. Adjuvant therapy for patients with colon and rectal cancer: clinical indications for multimodality therapy in high-risk groups and specific surgical questions for future multimodality trials.
    Steele G
    Surgery; 1992 Nov; 112(5):847-9. PubMed ID: 1440234
    [No Abstract]   [Full Text] [Related]  

  • 42. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
    Chua YJ; Zalcberg JR
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):595-604. PubMed ID: 18402526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
    Smalley SR; Benedetti JK; Williamson SK; Robertson JM; Estes NC; Maher T; Fisher B; Rich TA; Martenson JA; Kugler JW; Benson AB; Haller DG; Mayer RJ; Atkins JN; Cripps C; Pedersen J; Periman PO; Tanaka MS; Leichman CG; Macdonald JS
    J Clin Oncol; 2006 Aug; 24(22):3542-7. PubMed ID: 16877719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. S-phase fraction can predict event free survival in patients with pT2-T3N0M0 colorectal carcinoma: implications for adjuvant chemotherapy.
    Cascinu S; Ligi M; Graziano F; Del Ferro E; Valentini M; Grianti C; Bartolucci M; Catalano G
    Cancer; 1998 Sep; 83(6):1081-5. PubMed ID: 9740071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colorectal cancer.
    Waters JS; Cunningham D
    Lancet; 1999 Mar; 353(9157):1012-3. PubMed ID: 10459935
    [No Abstract]   [Full Text] [Related]  

  • 47. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.
    Ahmed S; Ahmad I; Zhu T; Arnold FP; Faiz Anan G; Sami A; Yadav SK; Alvi R; Haider K
    Dis Colon Rectum; 2010 Oct; 53(10):1432-8. PubMed ID: 20847626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Adjuvant therapy for colon cancer].
    Lordick F; Rosenberg R; Stein HJ; Peschel C; Siewert JR
    Dtsch Med Wochenschr; 2004 Oct; 129(44):2366-71. PubMed ID: 15497107
    [No Abstract]   [Full Text] [Related]  

  • 49. [A randomized controlled trial to evaluate the effect of adjuvant oral fluoropyrimidine derivative therapy after curative resection for stage II/III rectal cancer-adjuvant chemotherapy trial of S-1 for rectal cancer (ACTS-RC):].
    Oki E; Kakeji Y; Yoshida R; Ikeda K; Nishida K; Koga T; Egashira A; Tokunaga E; Morita M; Baba H; Maehara Y
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():138-43. PubMed ID: 16897990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjuvant chemotherapy for stage II colon cancer: the time has come.
    Mamounas EP
    Eur J Surg Oncol; 2000 Dec; 26(8):725-9. PubMed ID: 11087634
    [No Abstract]   [Full Text] [Related]  

  • 51. Adjuvant therapy for colon cancer: a historical perspective.
    Grem J
    J Natl Cancer Inst; 2004 Aug; 96(15):1116-7. PubMed ID: 15292377
    [No Abstract]   [Full Text] [Related]  

  • 52. Colorectal cancer: adjuvant chemotherapy for rectal cancer-an unresolved issue.
    Palta M; Czito BG; Willett CG
    Nat Rev Clin Oncol; 2014 Apr; 11(4):182-4. PubMed ID: 24642673
    [No Abstract]   [Full Text] [Related]  

  • 53. [IDEA study (International Duration Evaluation of Adjuvant Chemotherapy) for patients with stage III colon cancer: Possibility of reducing to 3 months treatment for 60% of the patients!].
    André T; Taieb J;
    Bull Cancer; 2018 Jun; 105(6):546-547. PubMed ID: 29776587
    [No Abstract]   [Full Text] [Related]  

  • 54. Current changes in the management and outcome of patients with curable colorectal cancer.
    Itah R; Greenberg R; Werbin N; Sacham-Shmueli E; Inbar R; Avital S
    Isr Med Assoc J; 2011 May; 13(5):300-3. PubMed ID: 21845972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improvements in 5-year outcomes of stage II/III rectal cancer relative to colon cancer.
    Renouf DJ; Woods R; Speers C; Hay J; Phang PT; Fitzgerald C; Kennecke H
    Am J Clin Oncol; 2013 Dec; 36(6):558-64. PubMed ID: 22868238
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic factors of colorectal cancer. Results of multivariate analysis of curative resection cases with or without adjuvant chemotherapy.
    Takahashi T; Kato T; Kodaira S; Koyama Y; Sakabe T; Tominaga T; Hamano K; Yasutomi M; Ogawa N
    Am J Clin Oncol; 1996 Aug; 19(4):408-15. PubMed ID: 8677916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The adjuvant therapy within the scope of the combined treatment of the rectum carcinoma].
    Kulieva NG; Zeĭnalov RS; Abdullaev AA; Akperov KS; Musaev IN
    Khirurgiia (Mosk); 2011; (10):20-4. PubMed ID: 22334899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy.
    Bouvier AM; Minicozzi P; Grosclaude P; Bouvier V; Faivre J; Sant M
    Dig Liver Dis; 2013 Aug; 45(8):687-91. PubMed ID: 23428703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Significance of Para-Aortic Lymph Node Dissection for Advanced or Metastatic Colorectal Cancer in the Current Era of Modern Chemotherapy.
    Arimoto A; Uehara K; Kato T; Nakamura H; Kamiya T; Nagino M
    Dig Surg; 2015; 32(6):439-44. PubMed ID: 26402333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? Against the proposal.
    Köhne CH
    Lancet Oncol; 2006 Jun; 7(6):516-7. PubMed ID: 16767832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.